Azenta reiterates 2025 guidance with 3-5% organic growth and EBITDA margin expansion
Q1 2025 Management View CEO John Marotta emphasized the company's focus on driving profitable growth and long-term shareholder value. He highlighted progress in operational excellence and portfolio ...
Hosted on MSN15d
Azenta elects Entrada CEO to Board of Directors
John Marotta, President and CEO of Azenta, praised Doshi's extensive experience in the biotechnology and pharmaceutical sectors, highlighting his strategic, operational, and commercial growth ...
Azenta reports Q1 adjusted EPS 8c, consensus 6c
Reports Q1 revenue $148M, consensus $145.96M. “Our first quarter results represent a strong start to fiscal 2025 as we see positive momentum in ...
Seeking Alpha9d
Azenta reiterates 2025 guidance with 3-5% organic growth and EBITDA margin expansion
CEO John Marotta emphasized the company's focus on driving profitable growth and long-term shareholder value. He highlighted progress in operational excellence and portfolio optimization ...